The State Organization Index provides an alphabetical listing of government organizations, including commissions, departments, and bureaus.
Top-requested sites to log in to services provided by the state
All licensed blood banks and transfusion services in Massachusetts are required to report transfusion-related adverse events using the Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) Hemovigilance Module.
Facilities must complete the required NHSN training and all enrollment steps to report through the Hemovigilance Module. All data must be reported according to the NHSN protocols.
Recorded training webcasts for staff on the NHSN methodology, definitions, and data entry are available on the CDC website:
Please note that reporting through the Hemovigilance Module does not replace the FDA's mandatory requirements for reporting blood transfusion baths or blood product deviation reporting.
The reporting of transfusion-related adverse events to the NHSN does not replace the reporting of Serious Reportable Events (SRE) by blood banks. Licensed blood banks must also continue to report patient death or serious injury that is associated with the unsafe administration of blood products as a Serious Reportable Event. Unsafe administration includes, but is not limited to hemolytic reactions and administering:
All such events should be reported to the Clinical Laboratory Program within 1 business day.